Davide Tortora is a scientist currently working at Abdera Therapeutics since April 2024, previously serving as a research scientist at AbCellera from June 2021 to November 2023, where leadership in antibody discovery campaigns contributed to multiple presentations at significant international conferences. Tortora's academic background includes a Ph.D. in Oncology and Cancer Biology from The University of British Columbia, combined with research experience as a postdoctoral researcher and teaching assistant at the same institution, and a master's researcher role at the University of California San Diego. Educational qualifications include a Bachelor's degree and a Master's degree in Molecular Biology from Università degli Studi di Padova. Throughout a diverse research career, Tortora has engaged in significant projects related to immune evasion in cancer, CRISPR technology, and therapeutic applications in oncology.